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Abstract 
In vertebrates gonadotropin-releasing hormone I (GnRH-I) is a key regulator of reproductive 
development and function. The receptor-binding activity of human GnRH-I can be modified 
by the presence of divalent copper. Thus, copper binding to N-terminal amino acids in 
GnRH-I induces structural changes that influence receptor interactions and downstream 
intracellular signalling cascades. It is not known if copper-binding is restricted to human 
GnRH-I or if it is also a feature of GnRH-type peptides that have been identified in other 
taxa. To investigate this, we have characterised copper binding to a recently discovered 
GnRH-type peptide from the starfish Asterias rubens (ArGnRH). Using a range of 
spectroscopic and biophysical techniques we show that this peptide can bind copper(II) and 
nickel(II). Copper(II) is bound in a square-planar, high-affinity (Kd ~10-12 M) site 
incorporating four nitrogen donor atoms from a histidine imidazole group, two amides and 
the N-terminal amine group. The ArGnRH copper affinity and geometry are quite different to 
GnRH-I suggesting the copper sites have evolved to suit the environment the peptides are 
exposed to. By comparing the copper binding sites in ArGnRH and human GnRH-I and 
conducting a phylogenetic analysis of GnRH-type peptide sequences from a range of species, 
we predict that copper-binding is an evolutionarily ancient feature of GnRH-type peptides 
that has been retained, modified or lost in different lineages.                
 
Keywords: gonadotropin-releasing hormone, copper, neuropeptide, echinoderm, ATCUN 
motif, starfish, Asterias rubens 
 
Significance to Metallomics: Gonadotropin-releasing hormone type neuropeptides are 
evolutionarily ancient molecules that regulate a variety of physiological processes in animals. 
Human gonadotropin-releasing hormone binds copper but it is not known if this is a general 
property of this neuropeptide family. Here we show that a starfish gonadotropin-releasing 
hormone type neuropeptide also binds copper and with very high affinity. Furthermore, based 
on phylogenetic sequence analysis we suggest that copper-binding is an ancestral feature that 
has evolved to suit different environmental conditions.       
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Introduction  
Gonadotropin-releasing hormone (GnRH; pQHWSYGLRPG-NH2) was discovered in 
1971 on account of its effect in triggering release of luteinizing hormone (LH) and follicle 
stimulating hormone from the pituitary gland in mammals.1 This action of GnRH is necessary 
for the onset of puberty and maintenance of reproductive function in adulthood.2 
Subsequently, a related neuropeptide (pQHWSHGWYPG-NH2) was discovered in mammals 
and this is referred to as GnRH-II, with the prototype peptide now known as GnRH-I. 
Investigation of the physiological roles of GnRH-II has revealed that it is likewise involved in 
regulating reproductive function, but it also has non-reproductive functions.3 GnRH-I and 
GnRH-II exert their effects in mammals by binding to distinct G protein-coupled receptors.3 
Investigation of the biochemical properties of GnRH-I revealed that it binds copper 
via the N-terminal pQH sequence, where the metal ion is coordinated via histidine amide and 
imidazole nitrogens, the pyroglutamate nitrogen, and a solvent molecule.4 Examination of the 
physiological relevance of copper binding to GnRH-I has revealed that copper-bound GnRH-
I has a higher affinity for its receptor than non-complexed GnRH-I, resulting in enhanced 
release of LH from female rats.5 This effect of copper has been linked to conformational 
changes that result in modification of receptor-dependent activation of downstream 
intracellular signalling pathways.3 Furthermore, the conformational changes make copper-
bound GnRH-I less susceptible to proteolytic degradation, which may contribute to its 
enhanced bioactivity in vivo.6, 7 However, the affinity of GnRH-I for copper is not high 
enough for the complex to survive intact after transit through the hypophyseal portal 
circulation, and it is proposed that GnRH-I binds copper directly in the anterior pituitary near 
to the gonadotropin releasing cells.8 
Analysis of the phylogenetic distribution of GnRH-related neuropeptides and their 
cognate G protein-coupled receptors has revealed that the evolutionary origin of this 
signalling system can be traced back to a common ancestor of bilaterian animals.9, 10 For 
example, it has been discovered that adipokinetic hormone (AKH; pQLNFTPNWGT-NH2) in 
insects and AKH-like peptides in nematodes are orthologs of vertebrate GnRH-type 
peptides.11, 12 However, copper binding has thus far only been examined for mammalian 
GnRH-I and it is not clear if this feature is restricted to the mammalian peptide or is a feature 
of the broader family. Recently, a GnRH-type neuropeptide (ArGnRH; 
pQIHYKNPGWGPG-NH2) and its cognate receptor (ArGnRHR) were identified in the 
starfish Asterias rubens (phylum Echinodermata) and a noteworthy feature of ArGnRH is that 
it has a histidine at position three.13 Previous studies on other peptides and proteins have 
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revealed that the presence of a histidine residue in the third position promotes high affinity 
binding of copper and nickel via a (NH2, 2N-, Nim) coordination mode in what is now termed 
an amino terminal copper and nickel (ATCUN) binding site.14 The ATCUN site has been 
observed in many albumins and neuropeptides and we have previously identified a precursor 
protein in A. rubens which generates several ATCUN-containing neuropeptides.15-17 In 
contrast to many ATCUN peptides, ArGnRH and GnRH-I have a pyroglutamate at the N-
terminus and the effect of this modification on copper or nickel coordination has not been 
investigated. However, analysis of GnRH-I suggests that its copper affinity is several orders 
of magnitude lower than that of the well characterised peptide GHK which contains a 
histidine at position 2 and a conventional N-terminal amine.8 Potentially, the pyroglutamate is 
responsible for the reduction in affinity, although other factors such as the different lengths of 
the peptides and the different methods used to estimate affinity must also be taken into 
consideration when comparing different peptides.     
   The objective of this study was to investigate the copper(II)- and nickel(II)-binding 
properties of ArGnRH and compare with the known metal-binding properties of GnRH-I. 
Furthermore, to gain insights into the evolution of metal binding by GnRH-type 
neuropeptides we investigate the phylogenetic distribution of the occurrence and position of 
histidine residues in the N-terminal region of GnRH-related neuropeptides.      
          
Experimental 
Asterias rubens gonadotropin-releasing hormone (ArGnRH, pQIHYKNPGWGPG-
NH2) was custom synthesised by PPR Ltd (Fareham, Hampshire, UK) at >95% purity. 
Synthetic GnRH-I was purchased from Auspep (Melbourne, Australia). All other chemicals 
were purchased from Sigma-Aldrich (Castle Hill, Sydney, Australia). The concentration of 
ArGnRH was determined using an extinction coefficient at 280 nm of the tryptophan (5690 
M-1cm-1) and tyrosine (1280 M-1cm-1) residues. The buffer used was either 10 mM 4-
ethylmorpholine (nEM) or 10 mM sodium phosphate (NaPi). A stock (50 mM) solution of 
copper was prepared as CuCl2·2H2O in metal-free MilliQ water (18 M, Millipore) and 
diluted to working concentrations on the day of use. Similarly, a stock (36 mM) solution of 
NiCl2-xH2O was prepared and diluted on the day of use.  
 
Electronic Spectroscopy. 
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UV/Visible electronic spectroscopy was performed on a Cary 100 UV-Vis 
spectrophotometer operated with Cary WinUV software. All spectra were collected using a 
1.0 cm path length cuvette over the range 200 – 800 nm at a scan rate of 300 nm/min.  
 
Mass Spectroscopy (MS). 
MS data were acquired on a XEVO-QToF (Waters Corp., Milford, MA, USA) 
operated in positive ion mode. The capillary voltage was 3.5 kV and spectra were collected at 
cone voltages of 30 V and 80 V, source temperature 80 C and over mass ranges of 200 to 
3000 Da. Spectra were collected and analysed using MassLynx software (Waters Corp., 
Milford, MA, USA). Peptide samples and copper complexes were prepared in water at 215 
M and diluted ×10 using a 1:1 acetonitrile:water solvent containing 0.1% formic acid. The 
diluted samples were applied via a direct infusion at a flow rate of 10 L/min.   
 
Circular Dichroism (CD) spectroscopy. 
CD spectra were collected on a Jasco J810 spectrometer. Spectra were collected over 
the range 300 – 800 nm, with data points every 2 nm, in a 1.0 cm path length square cuvette. 
Routinely, 10 scans were collected and averaged. The raw signal was converted to molar 
ellipticity ( M-1cm-1) using the equation  = /33000 × c × l, where c = concentration (M) 
and l = pathlength (cm). 
 
Nuclear Magnetic Resonance (NMR) spectroscopy. 
All NMR spectra were collected on a 300 MHz Bruker Avance spectrometer equipped 
with a 5 mm TXI probe and operated with Topspin 3.1 software (Bruker Biospin, Germany). 
Proton spectra were acquired over an 11 ppm spectral width comprising 64 K complex 
points, and the residual water signal was suppressed using a W5 watergate sequence. Spectra 
were processed using SpinWorks 4.18  Two-dimensional TOCSY spectra were acquired using 
a pulse program incorporating a DIPSI spin-lock sequence (80 ms) and gradient water 
suppression. Spectra were acquired over 11 ppm in both dimensions and processed using a 
π/2 shifted sine-squared window function in both directions, linear prediction to 512 real 
points in F1 and zero-filled to 2K real points in both dimensions.   
 
Electron Paramagnetic Resonance (EPR) Spectroscopy. 
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Continuous wave EPR spectra at ~9.4 GHz (X-band) were obtained on a Bruker 
Elexsys E500 spectrometer operated with Bruker Xepr software and equipped with a super 
high-Q cavity. The microwave frequency was calibrated with an EIP548B frequency counter. 
A temperature of 150 ± 5K was achieved using a nitrogen gas flow-through system linked to 
a Eurotherm B-VT-2000 temperature controller. The power was 8 mW, the modulation 
amplitude was 5G, the modulation frequency was 100 kHz and the sweep time was 120 s. 
Spectra were simulated using the least-squares fitting algorithm in Easyspin running in 
Matlab R2018a.19 The copper hyperfine and Zeeman interactions were simulated using 
matrix diagonalization, and after inclusion of nitrogen nuclei the nitrogen superhyperfine 
interactions were simulated using perturbation theory. Linewidths were fit using a correlated 
distribution of g- and A-values.20  
 
Estimation of the ArGnRH copper dissociation constant. 
The copper(II)-ArGnRH dissociation constant was estimated via a competitive metal-
ion capture procedure employing glycine as the competitor.8, 21 Individual [CuIIArGnRH] 
samples were prepared in nEM buffer (10 mM, pH 7.55) and glycine was titrated to a final 
concentration of 17.4 mM. Glycine forms a 2:1 complex with copper and this species is CD 
silent, therefore the spectra obtained during the titration represents only [CuIIArGnRH] and 
from this the fraction () of Cu(II)-bound ArGnRH can be determined. When  = 0.5, the 
dissociation constant, Kd = [Cu2+]free and [Cu2+]free, in the presence of glycine, is given by21:  
[Cu2+]free = 1/(1 + Ka1[gly] + Ka1Ka2[gly]2)  ([Cu2+]total - [CuIIArGnRH])    (1) 
The stepwise dissociation constants (Kd = 1/Ka) for [CuII(gly)2] at pH 7.55 are 0.89 M (Kd1) 
and 8.91 M (Kd2) 22. The affinity determined in this manner should be considered a 
maximum as previously described.23 
 
Investigation of the phylogenetic distribution of GnRH-type neuropeptides that have a 
histidine residue at position three 
To assess the evolutionary origin of the occurrence of a histidine residue at position 
three in ArGnRH, the sequences of neuropeptides that have been identified as ligands for 
GnRH-type receptors were assembled by surveying published literature in this field of 
research, which has been reviewed recently.10 The sequences of the peptides were then 
aligned manually and ordered in accordance with the known phylogenetic relationships of the 
taxa from which the peptides are derived.24, 25 In this way, it was possible to examine the 
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phylogenetic distribution GnRH-type neuropeptides with a histidine residue at position three 
and thereby investigate the evolutionary origin(s) of this characteristic.   
 
Results and Discussion 
ArGnRH binds copper in a high affinity, square planar complex. 
To assess the copper-binding ability of ArGnRH we first used electronic 
spectroscopy. The addition of Cu(II) to a solution of ArGnRH results in the appearance of a 
peak in the absorption spectrum at 530 nm (Figure 1A). With continued addition of copper, 
the absorption rises, but the slope of the binding curve changes beyond one equivalent Cu2+ 
(Figure 1A (inset)), suggesting a stoichiometry of 1:1. The peak at 530 nm is due to d-d 
transitions of the Cu2+ ion. The peak at 530 nm is different to that observed for Cu(II) binding 
to GnRH-I, which occurs near 590 nm (Figure 1A, dashed line).4, 8 The shift to higher energy 
for [CuIIArGnRH] compared to [CuIIGnRH-I] suggests that ArGnRH has stronger-field 
ligands than GnRH-I, most likely due to the inclusion of more N-donors in the complex at the 
expense of weaker O-donors. We next confirmed the 1:1 stoichiometry using mass 
spectrometry. The electrospray mass spectra of apo-ArGnRH and copper-bound peptide are 
shown in Fig. 1B. The spectrum of apo-ArGnRH shows predominant peaks at m/z 1335.59 
and m/z 1358.6 corresponding to ArGnRH and its sodium adduct, respectively. Addition of 
an equimolar amount of Cu2+ results in the spectrum in Fig. 1B(b). This spectrum has the 
same peaks corresponding to apo-ArGnRH, but also peaks corresponding to [CuIIArGnRH – 
3H]+ (m/z 1396.5) and the sodium adduct of the copper complex (m/z 1418.9). We next 
analysed a sample containing a ×10 molar ratio of Cu(II). The mass spectrum of this sample 
(Fig. 1B(c)) shows a high proportion of the [CuIIArGnRH – 3H]+ and its sodium adduct. At 
this high concentration of copper a small peak corresponding to dinuclear metal complex is 
apparent at m/z 1457.5. Spurious binding of an additional copper atom may account for the 
lack of a distinct plateau in the UV/Vis titration data beyond one equivalent copper (Fig. 1A 
inset). Taken together with the electronic spectroscopy results, the MS data suggests that the 
most stable complex is [CuIIArGnRH]. We predict that the loss of three protons to form the 
complex at m/z 1396.5 is due to loss of amide protons driven by the copper binding.     
To determine the ligands contributing to the coordination environment in 
[CuIIArGnRH] we used EPR spectroscopy. The experimental EPR spectrum of a frozen 
solution of [CuIIArGnRH] (Figure 1C, exp) shows a typical axial-type spectrum copper 
complex (gx, gy < gz). Mapping the gz and Az values to the plots developed by Peisach and 
Blumberg suggests the copper in [CuIIArGnRH] is coordinated to 4N or 3N1O ligands.26 The 
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involvement of nitrogen ligands is evident because the perpendicular region (gx/y, 320-340 
mT) of the experimental spectrum contains peaks due to coupling of the unpaired electron on 
copper to the nuclear magnetic moment of coordinated nitrogen atoms (superhyperfine (shf) 
coupling). The number of shf peaks is correlated to the number of coordinated nitrogen atoms 
and these are more easily observed in the second differential spectrum (Fig. 1C, inset). In an 
ideal complex the number of coordinated nitrogen atoms (n) is related to the number of shf 
peaks by 2n+1, so four N ligands gives rise to nine shf peaks. In Fig. 1C, [CuIIArGnRH] has 
more than nine peaks in the gx,y region. The gx,y region can be complicated by the presence of 
more than one species as well as distortion away from ideal symmetry. The low value of Az 
for [CuIIArGnRH) can be associated with rhombic distortion and therefore the spectrum in 
Fig. 1C (and inset) was simulated assuming a distorted complex (i.e. gx ≠ gy ≠ gz) with four 
magnetically equivalent nitrogen donor atoms using the spin Hamiltonian parameters given in 
table 1. The simulated spectrum shows very good agreement with the experimental spectrum 
(Fig. 1C), which confirms the presence of four coordinating nitrogen atoms. However, 
although the number and position of the superhyperfine coupling peaks are well simulated, 
the intensity of the lines is not accurate, which may indicate the presence of a small amount 
of a 3N1O complex as suggested by the Peisach-Blumberg analysis.27     
To determine the identity of the nitrogen donors we first used NMR. The presence of 
paramagnetic Cu(II) causes line-broadening of atoms within about 7 Å of the copper centre. 
In the 1H NMR spectra of [CuIIArGnRH] acquired prior to the addition of copper (Figure 2A, 
apo) and after the addition of low concentrations of copper (Figure 2A, 0.08 and 0.24 eq. 
Cu(II)) we see significant broadening of peaks arising from protons on the histidine 
imidazole group (C2H and C4H). The presence of 0.24 eq. copper has effectively broadened 
these peaks beyond detection. Other peaks that show broadening and a loss of intensity are 
those near 2.85 ppm (Figure 2A), attributable to the histidine H protons, and peaks near 1.7 
ppm. The peaks at 1.7 ppm are difficult to identify given an overlap of several different 
protons, however this region does contain contributions from pyroglutamate protons. In 
general there is a minor broadening of all of the peaks in the spectrum, presumably due to the 
small size of the peptide where all protons are relatively near the metal centre. The nitrogen 
ligands were also identified using CD spectroscopy. The CD spectrum of [CuIIArGnRH] 
(Figure 2B, solid line) shows negative peaks at 325 and 575 nm, and a positive peak at 490 
nm. The presence of peaks in the visible region is due to chirality in the metal binding site 
and is usually associated with binding to main-chain amide nitrogen atoms.28 CD peaks near 
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325 nm can be attributed to NIm  Cu(II) transitions suggesting, in accord with the NMR 
data, copper coordination to the histidine imidazole nitrogen atom. Previous analysis of 
copper complexes by CD spectroscopy has highlighted how the appearance of the visible 
peaks correlates with structure.29 The positive band at 460 nm and weaker negative band at 
575 nm is similar to the spectrum of H2N-xxH tripeptides in which the metal is coordinated to 
histidine, the amino terminal N and amide nitrogens and where the His imidazole group is 
located below the plane of the backbone atoms.29 ArGnRH has the N-terminal sequence 
pQIH so it is not unreasonable that it should adopt similar copper complexes to simple 
tripeptides. In general, the effect of a N-terminal pyroglutamate on copper coordination has 
not been investigated, but even though ArGnRH has a pyroglutamate it appears that it forms a 
copper complex having the same, or very similar, geometry as a peptide with a free N-
terminal amine. Additionally, pyroglutamate as the first amino-acid is similar to having 
proline in position 1 which has previously been shown to not modify oligopeptide metal 
binding.30 Although the CD spectra of [CuIIArGnRH] and [CuIIGnRH-I] (Figure 2B, dashed 
line) both highlight the inclusion of imidazole coordination, there is significant difference in 
the visible region, which is consistent with [CuIIGnRH-I] adopting a 3N1O copper complex, 
but [CuIIArGnRH] having a 4N environment.   
Peptides and proteins that contain copper-binding H2N-xxH sequences (termed 
ATCUN motifs) can have high affinity binding.31 In mammalian biology, nanomolar copper 
dissociation constants are considered physiologically relevant. However, in marine animals 
like starfish this will not be the case because the copper concentration in seawater is low (10-8 
M) and the presence of high-affinity chelating compounds means that the free copper 
concentration is very low (10-11 -10-12 M).32 The ionic composition of starfish body fluids is 
similar to that of seawater and therefore proteins having only a nanomolar dissociation 
constant are unlikely to be metallated to any extent. To assess the affinity of ArGnRH for 
copper we used a competitive metal-ion capture technique employing the amino acid glycine 
as a competitor. Glycine was titrated into a solution of [CuIIArGnRH] and CD was used to 
monitor the abstraction of copper from the complex. The loss of intensity of the CD peaks 
(Figure 2C) correlates with the binding of copper by glycine to form non-chiral [Cu(gly)2]. 
The concentration of glycine required to abstract half the copper from [CuIIArGnRH] ( = 
0.5) was estimated based on the concentration of glycine required to reduce the intensity of 
the CD band at 490 nm to half its original value which was estimated as being 10.8 mM 
(Figure 2C, dashed line) corresponding to a [gly]:[ArGnRH] ratio of 73:1. Using an 
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identical method we previously established that mammalian GnRH-I lost 50% of bound 
copper at a [gly]:[GnRH-I] ratio of  3:1, suggesting that ArGnRH has a copper affinity 
much higher than mammalian GnRH-I.8 Indeed, using eq. 1 we estimate a dissociation 
constant of  5.2 × 10-12 M which is several orders of magnitude lower than mammalian 
GnRH-I (~0.9 × 10-9 M). However, unlike the loss of copper from GnRH-I,8 the abstraction 
of copper from ArGnRH by glycine was not linear over the entire glycine concentration 
range, which may be due to various reasons including peptide structural changes or formation 
of ternary complexes. Further analysis of the underlying reasons for the non-linear 
abstraction of copper was not undertaken and therefore the dissociation constant must be 
considered an estimate. Nevertheless, the result is entirely consistent with the different 
binding sites, GnRH-I has a histidine in position 2 (pQH…) whereas ArGnRH has a histidine 
in position 3 (pQIH…), and a dissociation of this magnitude is in a similar range to other 
proteins and peptides having a H2N-xxH copper-binding sequence.31           
 
ArGnRH binds Ni(II) forming a 5-coordinate, diamagnetic complex.     
The binding of copper by peptides and proteins having an ATCUN motif (histidine at 
position 3) is often mimicked by Ni(II) binding. The copper experiments indicate that the N-
terminal pyroglutamate does not impede the copper coordination, suggesting that Ni(II) 
should also bind. Although both Cu(II) and Ni(II) can promote deprotonation of amide 
nitrogens, Ni(II) generally requires higher pHs to do so.30 To investigate metal binding we 
first titrated Ni(II) into pH 7.2 and pH 9.3 solutions of ArGnRH and followed the binding by 
electronic spectroscopy. The spectra show that at pH 7.2 there is little evidence of binding 
either in the UV or the visible regions of the spectrum (Figure 3, the peak at 280 nm is due to 
n/* transitions of aromatic amino acids). In contrast, increasing the pH to 9.3 results in 
the formation of a peak near 260 nm as well as in the region between 400 and 500 nm. The 
intensity and wavelength of the peak near 260 nm is indicative of a ligand-to-metal charge 
transfer transition (note that the high absorption makes analysis inaccurate).33 The weak 
peaks at 410 and 490 nm are d-d transitions and peaks in this area are usually due to 
diamagnetic complexes. We have observed similar peaks upon the addition of Ni(II) to A. 
rubens SALMFamide-type neuropeptides, but we observed only the presence of a single 
absorption band near 420 nm.17 A single band is often attributed to a diamagnetic square-
planar complex, but Ni(II) can also adopt a five-coordinate, square pyramidal geometry that 
has C4v symmetry and is a low-spin, diamagnetic complex.33 These complexes have more 
12 
 
than one peak in the visible region and we predict that the two peaks at 410 and 490 nm 
indicate that Ni(II) in [NiIIArGnRH] is in a 5-coordinate geometry. Indeed, we observed two 
peaks in the same region of the electronic spectrum of Ni(II) bound to peptides derived from 
the prion protein, which was subsequently shown to correspond to a coupled, 5-coordinate 
Ni(II).34, 35  
The diamagnetic nature of the complex means that NMR can be used to help identify 
coordinating ligands. The aromatic/amide region of the NMR spectrum of apo-ArGnRH is 
shown in Figure 4A (lowest trace), and the assignment of the peaks is highlighted. At the 
high pH of this experiment (pH ~ 9.2) the amide protons are not observed due to exchange 
with the buffer. The addition of Ni(II) causes clearly observable changes to this region of the 
spectrum, with peaks due to His imidazole protons (C4H and C2H) and the Tyr aromatic side 
chain (H2,6 and H3,5) in the apo peptide decreasing in intensity and a whole new set 
appearing (e.g. at 6.59 ppm and 6.83 ppm for His3 imidazole protons). The appearance of a 
Ni(II)-bound set along with the apo peaks indicates that the on-off rate of Ni(II) is slow 
compared to the NMR timescale. At approximately 0.4 eq. Ni(II) there is almost equal 
intensity of peaks due to apo and Ni(II)-bound ArGnRH, and there is no evidence of peaks 
due to apo-ArGnRH once one equivalent has been reached. This is consistent with a UV/Vis 
titration (data not shown) and indicates a binding stoichiometry of 1:1. The assignment of 
peaks that have moved upon Ni(II) binding are shown in Figure 4A (top trace) suggesting 
that both His3 and Tyr 4 are involved in coordination. The lack of any changes to side chain 
protons of Asn5 and Trp9 supports the idea that Ni(II) binding is occurring at the N-terminal 
region. Analysis of the aliphatic region shows that there are chemical shift changes to many 
peaks; notably the side-chain methyl groups of Ile2 have moved in the Ni(II)-bound peptide 
(Figure 4B). The -CH3 doublet has moved 0.364 ppm downfield upon Ni(II) binding, and 
the -CH3 triplet has moved 0.106 ppm downfield. In this case, the downfield shifts indicate a 
deshielding effect due to magnetic anisotropic effects of an aromatic group, which is most 
likely due to movement of the tyrosine and not the tryptophan. The -CH3 group is relatively 
more effected and the deshielding suggests it is located near the plane of the aromatic ring. 
Previously, mammalian GnRH-I was predicted to bind Ni(II) via the same ligands it binds 
copper (N-terminal pyroglutamate nitrogen, an amide and the His2 imidazole nitrogen) and it 
is likely that ArGnRH uses similar ligands as its basis for binding Ni(II).4  The requirement 
for high pH values to promote binding suggests amide coordination, and, with changes to the 
His imidazole proton chemical shifts, we suggest that the binding site is comprised of the N-
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terminal pQ nitrogen, the amides of Ile2 and His3 and a His3 imidazole nitrogen similar to 
conventional ATCUN sites. It is highly unlikely that the chemical shift changes of the Tyr 
aromatic protons are due to coordination to the Tyr amide nitrogen, rather, and in contrast to 
GnRH-I, we predict that the tyrosine changes are due to coordination of Ni(II) to the 
hydroxyl oxygen, which may displace the hydroxyl proton. Indeed, and not unexpectedly, 
there are substantial chemical shift changes to Tyr aromatic protons after deprotonation (pKa 
= 10.1). We predict that Ni(II) is coordinated with a {NH2, 2N-, Nim, OTyr} donor set, and if 
the tyrosine oxygen is coordinated in the apical position, i.e. sits above the plane of the 
nitrogen ligands, then a structure can be achieved where the Ile methyl groups are located in 
the plane of the aromatic ring. A schematic diagram of the copper and nickel ArGnRH 
complexes consistent with the experimental evidence is shown in Figure 5.      
 
The phylogenetic distribution and evolutionary origin(s) of N-terminal histidines in GnRH-
type neuropeptides  
Investigation of the occurrence of a histidine residue at the third position in GnRH-
type neuropeptides revealed that it is not unique to A. rubens, but it is also a feature of other 
echinoderms, including other starfish species,36 brittle stars,37 and sea urchins38 (Figure 6). 
However, GnRH-type neuropeptides that have been identified in other invertebrate 
deuterostomes do not have this feature. Thus, GnRH-type neuropeptides in the urochordate 
Ciona intestinalis have a histidine in position two, in common with GnRH-type 
neuropeptides in humans and other vertebrates (Figure 6). What about in the other branch of 
the Bilateria – the protostomes? It appears that histidine residues are typically not present in 
the GnRH-type neuropeptides of protostomes. Thus, GnRH-type neuropeptides in the 
nematode C. elegans and the annelid Platynereis dumerilli do not have histidine residues. 
Likewise, the paralogous AKH/RCPH-type and ACP-type GnRH-related neuropeptides of 
arthropods also do not contain histidine residues. Interestingly, however, GnRH-type 
neuropeptides in molluscs have a histidine residue in the third position, as exemplified by the 
Aplysia californica GnRH-type neuropeptide shown in Figure 6.10, 39 Interestingly, the N-
terminal sequence of A. californica GnRH (AcGnRH) is very similar to ArGnRH, with the 
first three residues being identical (pGlu-Ile-His) and the fourth residue structurally similar 
(Tyr/Phe). Therefore, the biophysical properties of AcGnRH with respect to copper binding 
are likely to be very similar to those reported here for ArGnRH. 
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What is the significance of the occurrence of GnRH-type peptides with a histidine at 
the third position in both echinoderms and molluscs? One possible explanation is that this is a 
feature that has evolved independently in both phyla. Alternatively, because this feature 
occurs in both the deuterostome branch (echinoderms) and protostome branch (molluscs) of 
the Bilateria, it may have been a characteristic of the GnRH-type neuropeptide present in the 
common ancestor of protostomes and deuterostomes, but with subsequent loss in multiple 
lineages. An argument in favour of the latter scenario is the occurrence of a histidine residue 
at position two in the GnRH-type neuropeptides of chordates, which could be explained by a 
mutation-induced loss of a codon in the position between the N-terminal glutamine-encoding 
codon and the histidine-encoding codon in the GnRH gene of a common ancestor of the 
chordates. Further evidence that the presence of a histidine residue in the N-terminal region 
of GnRH-type neuropeptides, although not necessarily at position three, can be found from 
analysis of the sequences of corazonin-type neuropeptides, which are paralogs of GnRH-type 
neuropeptides. Corazonin itself (pQTFQYSRGWTN-NH2), which was first discovered in 
insects, does not contain a histidine residue. However, orthologs of corazonin that have been 
discovered in echinoderms, hemichordates and molluscs contain a histidine residue in their 
N-terminal region. For example, a corazonin-type neuropeptide in i). the starfish A. rubens 
has the sequence HNTFTMGGQNRWKAG-NH2, ii). the hemichordate S. kowalevskii has 
the sequence pQPHFSLKDRYRWKP-NH2 and iii). the mollusc A. californica has the 
sequence pQNYHFSNGWYA-NH2.10, 13 The gene duplication event that gave rise to the 
paralogous GnRH-type and corazonin-type neuropeptides probably occurred in a common 
ancestor of the Bilateria.10, 13 Therefore, the occurrence of histidine residues in the N-terminal 
region of at least some GnRH-type and some corazonin-type neuropeptides suggests that this 
was probably a feature of the common ancestral neuropeptide, which has then been variously 
retained or lost in representatives of both of the descendent neuropeptide families. 
 
What is the functional significance of a high-affinity copper- and nickel-binding site in 
ArGnRH and other GnRH-type neuropeptides? 
Recent investigation of the functional consequences of copper coordination to 
mammalian GnRH-I has revealed that the complex modifies receptor-mediated activation of 
downstream intracellular signalling pathways compared to apo-GnRH-I.7 This activity is 
complemented by the ability of the copper-complex to resist degradation by extracellular 
peptidases and it is not unreasonable to speculate that copper-bound ArGnRH will have 
similar properties.6 In ArGnRH, the ATCUN-motif drives high-affinity copper binding and 
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we can predict that the complex will also have reasonably high stability. Recent work by 
Miyamoto et al. has shown that the presence of hydrophobic, bulky amino acids at position 1 
and 2 of the ATCUN motif is key to enhanced stability.40 ArGnRH has the N-terminal 
sequence pQIH and the isoleucine is likely to support high stability, due in part to sterically 
hindering access of competitors to the metal centre.40 Indeed, the ability of [CuIIArGnRH] to 
survive the sample conditions (acidic conditions) and the ionisation process during ESI-MS 
(Fig.1B) supports high stability. The difference in copper affinity between mammalian 
GnRH-I and ArGnRH may reflect the chemical composition of the milieu into which they are 
released physiologically. Thus, GnRH-I does not need a very high affinity because, once out 
of the hypophyseal portal circulation, it can likely obtain copper from the relatively copper-
rich anterior pituitary. In contrast, because the extracellular milieu in starfish has a similar 
ionic composition to seawater, ArGnRH probably competes with other high-affinity 
components to obtain and retain copper in a copper-depleted internal environment.41 The role 
of Ni(II) in ArGnRH function may be similar to that of copper. Ni(II) in coastal seawater can 
reach 5 g/L as a mix of aqueous Ni2+ and as complexes with inorganic ligands, e.g. as 
NiCO3.42 Given the changes that Ni(II) induces in the structure of ArGnRH in order to form 
[NiIIArGnRH] (Fig. 4) we predict that Ni(II)-binding may alter receptor activation compared 
to ArGnRH. The recent identification of the receptor for ArGnRH now allows these 
predictions to be experimentally tested.13 How the Cu(II)- and Ni(II)-binding to ArGnRH 
compares and relates to GnRH-type peptides in other species remains to be determined. 
Notably, some peptides contain more than one histidine, including mammalian GnRH-II 
(Figure 6), but the impact on copper and nickel affinity, stability and peptide function has not 
been investigated for these peptides.    
 
Conclusion 
In this work we have characterised copper and nickel binding to the recently 
identified GnRH-type neuropeptide from the starfish A. rubens. To the best of our 
knowledge, this work is the first investigation of copper and nickel binding to a GnRH-type 
neuropeptide from a non-mammalian species. The copper binding characteristics of ArGnRH 
are entirely consistent with the presence of an ATCUN motif, and five-coordinate nickel 
binding is not unprecedented in this motif.14 Unlike mammalian GnRH-I, the presence of 
both copper and nickel in seawater suggests that both metals may be relevant for ArGnRH 
function. Furthermore, the occurrence of an N-terminally located histidine residue in GnRH-
16 
 
related neuropeptides from a variety of phyla suggests that copper-binding in this family of 
neuropeptides is an evolutionarily ancient property that can be traced back to the common 
ancestor of the Bilateria, but with subsequent loss in some lineages (e.g. in insect AKH-type 
neuropeptides).    
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Figure legends. 
Figure 1. ArGnRH binds one equivalent of Cu(II) in a four-nitrogen environment. (A) 
Titration of ArGnRH (121.5 M, 10mM nEM, pH 7.3) with Cu2+ results in an absorption 
peak at 530 nm (black, solid line). The slope of the binding curve changes at one equivalent 
of added copper, suggesting a 1:1 stoichiometry (inset). The maximal absorption wavelength 
at 530 nm is blue-shifted compared to mammalian GnRH1 (red, dotted line) which has a 
maximal absorption near 590 nm. (B) Mass spectra of (a) apo-ArGnRH, (b) [CuIIArGnRH] 
and (c) ArGnRH in the presence of excess (×10 molar equivalents) Cu(II). All samples are 
21.5 M ArGnRH. (C) First derivative experimental EPR spectrum of copper-bound 
ArGnRH (350 M, 10mM nEM, pH 7.4)(black solid line, exp.) shows features typical for 
axially coordinated Cu2+. The experimental spectrum can be well simulated (red dotted line, 
sim.) assuming the metal has four nitrogen donor groups and with spin Hamiltonian 
parameters given in table 1. The second derivative expanded at gx/y (inset) highlights the 
presence of nitrogen coupling (black solid line is experiment, red dotted line is simulation). 
 
Figure 2. ArGnRH uses His3 to bind copper(II) with high affinity. (A) Titration of 
ArGnRH (316 M, 10mM NaPi, pH 7.4) with Cu2+ results in broadening and loss of peaks 
due to histidine imidiazole C2 and C4 protons (arrowed at 6.75 and 7.6 ppm). Peaks at 2.8 
ppm (expanded right) also show broadening and can be attributed to histidine H protons. (B) 
The CD spectrum of [CuIIArGnRH] (black solid line) is similar to mammalian [CuIIGnRH1] 
(red dotted line) between 200 and 300 nm but is different in the visible region. The difference 
is consistent with different donor groups and geometries in the two complexes. (C) Titration 
of [CuIIArGnRH] (148.5 M, 10 mM nEM, pH7.4) with glycine shows that a high glycine 
concentration is required to abstract Cu2+ from [CuIIArGnRH]. The dashed line represents the 
glycine concentration at which [CuIIArGnRH] has lost 50% copper. The affinity of ArGnRH 
for copper can be estimated as described in the text. 
 
Figure 3. ArGnRH binds Ni(II). The addition of Ni(II) to apo-ArGnRH (293.5 M, 10 mM 
nEM) results in the formation of a complex at pH 9.3 but not at pH 7.2. At pH 9.3, the 
presence of an absorption at ~250 nm can be attributed to a ligand-to-metal-charge transfer 
transition, whilst the two peaks between 400 and 500 nm can be attributed to d-d transitions 
in a five-coordinate, square-pyramidal diamagnetic complex.33 
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Figure 4. NMR analysis of Ni(II) binding to ArGnRH. (A) The titration of Ni(II) into 
ArGnRH (500 M, 10mM nEM, 10% D2O, pH 9.3) results in a change in the aromatic region 
of the NMR spectrum (6.5– 7.6 ppm). Peaks due to Asn5 and Trp9 are not affected, but all 
others in the apo-spectrum (lowest trace) are progressively lost and a new set become 
apparent. At one equivalent of Ni(II) only the new set of peaks are apparent. The shifted 
protons are the histidine imidazole C2 and C4 protons, and the tyrosine C2,6 and C3,5 
aromatic ring protons. In the aliphatic region (B) a notable shift of peaks as occurred to the 
methyl protons of Ile2 (arrowed), although shifts are noticeable throughout the spectrum. 
Note that spectra in the aliphatic region were acquired on ArGnRH in H2O/10%D2O, pH9.3 
due to the unavailability of deuterated nEM.  
 
Figure 5. Schematic of the ArGnRH copper and nickel sites. (A) ArGnRH binds Cu2+ in a 
square-planar, four-nitrogen site and (B) Ni2+ in a five-coordinate square-pyramidal site with 
the tyrosine phenolate oxygen the apical donor group. 
 
Figure 6. Phylogenetic diagram showing the occurrence of histidine residues in GnRH-
type neuropeptides from different taxa. Bilaterian animals comprise two clades, the 
deuterostomes (e.g. Chordates and Echinoderms) and protostomes (e.g. molluscs, annelids, 
nematodes and arthropods). The positions of histidine residues (red) in the N-terminal region 
of peptides are shown. Peptides that have a histidine in the third position (shaded in grey) 
include the Asterias rubens GnRH-type peptide (ArGnRH), which has been shown in this 
study to have a high-affinity copper binding site, and a peptide in the mollusc Aplysia 
californica (A cal), which is predicted to also have a high-affinity copper binding site. 
Because the occurrence of a histidine residue at position three is a feature of both a 
deuterostomian phylum (echinoderms) and a protostomain phylum (molluscs), this may be an 
evolutionarily ancient characteristic that can be traced to the common ancestor of the 
Bilateria but with subsequent positional modification or loss in other lineages. Sequence 
abbrevations: pQ = N-terminal pyroglutamate; a = C-terminal amide. Species abbreviations: 
A. rub (Asterias rubens; Phylum Echinodermata), S. pur (Strongylocentrotus purpuratus; 
Phylum Echinoderma), H. sap (Homo sapiens; sub-phylum Vertebrata, phylum Chordata), C. 
int (Ciona intestinalis; sub-phylum Urochordata, Phylum Chordata), A. cal (Aplysia 
californica; Phylum Mollusca), P. dum (Platynereis dumerilli; phylum Annelida), C. ele 
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(Caenorhabditis elegans; Phylum Nematoda), A. gam (Anopheles gambiae; Phylum 
Arthropoda). 
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Table 1. 
Spin Hamiltonian parameters for [CuIIArGnRH]. 
 
    aUnits are ×10-4 cm-1 
Complex gx gy gz Axa(63Cu) Aya(63Cu) Aza(63Cu) Axa(14N) Aya(14N) Aza(14N) Ref.
[CuIIArGnRH] 2.063 2.034 2.250 13.3 12.7 173.3 14.0 15.7 8.3 This work
[CuIIGnRH] 2.045 2.045 2.207 6.67 6.67 176.7 na na na Gul et al.8
